Skip to main content

TYVASO and TYVASO DPI are approved for the treatment of pulmonary hypertension associated with interstitial lung disease (PH-ILD; WHO Group 3) to improve the ability to exercise.

Skip to main content

Cost assistance

ASSIST can help you determine if you qualify for United Therapeutics’ patient assistance programs.
Call ASSIST at 1-877-864-8437 .
Eligible patients may pay as little as a $0 co-pay for each prescription of TYVASO or TYVASO DPI.

Co-Pay Assistance Program*

With the TYVASO Co-Pay Assistance Program, most eligible patients pay as little as a $0 co-pay for each prescription of TYVASO or TYVASO DPI.

Enroll today

Learn how to enroll at www.UTcopay.com or call ASSIST at 1-877-864-8437.

Get full program details and Terms and Conditions.

*Eligibility requirements for this Program are:

  • You must be 18 years or older to use this Program
  • Patients using Medicare, Medicaid, or any other state or federal government program to pay for their medications are not eligible. Patients who start utilizing government coverage during the term of the Program will no longer be eligible
  • The Program is valid only for patients with commercial (also known as private) insurance who are taking the medication for an FDAapproved indication
  • Eligible patients must be a resident of the United States or Puerto Rico. The Program is subject to additional state law restrictions. Patients residing in select states may not be eligible for the Program

DPI=dry powder inhaler.